Tianeptine product; selling, giving, or distributing, civil penalty.
Virginia bill establishes civil penalties for selling or distributing tianeptine products, targeting an unregulated substance marketed as a supplement with opioid-like effects.
Virginia bill establishes civil penalties for selling or distributing tianeptine products, targeting an unregulated substance marketed as a supplement with opioid-like effects.
SB 106 establishes civil penalties for the selling, giving, or distributing of tianeptine products in Virginia. Tianeptine is a atypical antidepressant that is not FDA-approved for use in the United States but is marketed as a dietary supplement or nootropic (often called "gas station heroin"). The bill creates a regulatory framework to restrict access to this substance through civil rather than criminal enforcement mechanisms.
Tianeptine has gained popularity as an unregulated substance sold in convenience stores and online, with users reporting opioid-like effects and dependence potential. Virginia's action addresses a growing public health concern where a pharmaceutical product is being sold outside traditional medical channels without FDA oversight. The bill demonstrates state-level attempts to control emerging drug trends before they require more severe criminal penalties.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.